Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Psilocybin × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Interventions

Cyclophosphamide 9 Surveys and Questionnaires 8 fludarabine phosphate 6 Whole-Body Irradiation 6 Peripheral Blood Stem Cell Transplantation 6 Busulfan 6 Methotrexate 5 Educational Status 5 Early Intervention, Educational 5 Tacrolimus 4 Mycophenolic Acid 4 Methods 4 Interviews as Topic 4 Immunohistochemistry 4 Gene Expression Profiling 4 Epoetin Alfa 4 Decitabine 4 Cyclosporine 4 Celecoxib 4 Biopsy 4 Antilymphocyte Serum 4 fludarabine 3 Sirolimus 3 Radiotherapy 3 Melphalan 3 Imiquimod 3 Fentanyl 3 Etoposide 3 Endoscopic Mucosal Resection 3 Darbepoetin alfa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡